EP0040355A2 - Procédé de réduction partielle d'acides stéroide-21-carboxyliques et de leurs esters en stéroide-21-alcools - Google Patents

Procédé de réduction partielle d'acides stéroide-21-carboxyliques et de leurs esters en stéroide-21-alcools Download PDF

Info

Publication number
EP0040355A2
EP0040355A2 EP81103421A EP81103421A EP0040355A2 EP 0040355 A2 EP0040355 A2 EP 0040355A2 EP 81103421 A EP81103421 A EP 81103421A EP 81103421 A EP81103421 A EP 81103421A EP 0040355 A2 EP0040355 A2 EP 0040355A2
Authority
EP
European Patent Office
Prior art keywords
steroid
pregna
compounds
general formula
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP81103421A
Other languages
German (de)
English (en)
Other versions
EP0040355B1 (fr
EP0040355A3 (en
Inventor
Wolfgang Dr. Preuss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP0040355A2 publication Critical patent/EP0040355A2/fr
Publication of EP0040355A3 publication Critical patent/EP0040355A3/de
Application granted granted Critical
Publication of EP0040355B1 publication Critical patent/EP0040355B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)

Definitions

  • the invention describes an improved and simplified process for partial particular e-R production of C21-carboxylic acid group in the corresponding steroid carboxylic acids having a A -3-one or ⁇ 1,4 -3-on configuration in the A ring of the steroid skeleton to the corresponding C21 -Alcohol function. If appropriate, further functional groups can also be present in the steroid structure, which remain completely or largely unaffected by this partial reduction.
  • Progesterone (4-pregnen-3,20-dione) and in particular progesterone derivatives with an oxygen function in the 11-position (11-oxo, 11 ⁇ -OH, 11 ⁇ -OH) of the formulas (1) to (3 ) are excellent and partly technically used starting materials for the synthesis of precursors of hydrocortisone (cortisol) and finally hydrocortisone itself.
  • a reaction scheme for this route can be found, for example, in LF Fieser, M. Fieser "Steroids", pages 737, 738, Verlag Chemie, Weinheim, 1961. Details include the original literature JA Hogg et al, J. Am. Chem. Soc. 77, 4436 (1955), and U.S. Patents 2,683,724 and 2,770,184.
  • reaction sequence is shown here somewhat shortened using the example of 11-keto-progesterone (4):
  • Dehydroprogesterone and its corresponding derivatives are distinguished by the 3-keto-1,4-diene structure of the A ring, as indicated in the following formulas (Ia) to (3a):
  • Difficulties in particular in the series of steroid compounds with 1,4-diene-3-keto structure are the partial reduction of the C21-carboxylic acid grouping to the corresponding C21-alcohol function. The reason for this is the lack of protection of the A ring in compounds of the dehydroprogesterone series.
  • the present invention is based on the object of demonstrating a way in which a partial reduction of a C-21 carboxylic acid function in the C17 side chain of steroid compounds is possible, even if there are comparatively sensitive further functional groups in the steroid ring structure.
  • further functional groups are in particular the A -3-one structure, the ⁇ 1,4 -3-one structure, further double bonds in the system, in particular in the 17 (20) position and optionally the 9 (11) position, and possible oxygen functions in the 11 position.
  • Starting materials are particularly important for all these compounds. which have the ⁇ 1,4 -3-one structure in the A-ring of the steroid skeleton.
  • the object of the invention was furthermore to enable a partial or at least largely partial reduction of the carboxyl group function in C 21 without the use of special separate protecting groups for the A-ring structure.
  • the invention accordingly relates to a process for the partial reduction of ⁇ 4,17 (2O) - and optionally further double bonds in the 1 (2) and / or 9 (11) position having C 21 steroid carboxylic acids and their esters of the general formula I in which R is hydrogen or a hydrocarbon radical and A is hydrogen, hydroxyl or, together with the carbon atom substituted by A, represents a carbonyl group, and finally, instead of the substituent A, an additional olefinic double bond in the 9 (11) position can also be present, to C 21 Steroid alcohols of the general formula II in which Z has the meaning of A, but here means hydroxyl instead of the carbonyl group.
  • the process according to the invention is characterized in that the starting compound of the general formula I which is unprotected in the A ring of the steroid system is reacted with diisobutyl aluminum hydride (D I B A H) in such amounts that the reduction of all O-containing functional groups to the hydroxyl group takes place , whereupon the aluminum-containing reaction intermediate is subjected to the selective Oppenauer oxidation to the 3-keto compound in a manner known per se.
  • D I B A H diisobutyl aluminum hydride
  • the reduction is carried out without a protecting group for the 1,4-diene-3-keto system of the A ring. Instead, the reducing agent is used in an amount that reduces both the ester group and the 3-keto group. Neither the double bonds of the A ring nor the 17 (20) double bond are attacked.
  • the alkoxyaluminum derivative (11), which can be assumed to be an intermediate, is usually not isolated, but, under suitable mild conditions, is directly subjected to selective Oppenauer oxidation by adding an alcohol / ketone mixture (for example isopropanol / acetone).
  • an alcohol / ketone mixture for example isopropanol / acetone.
  • the 3-keto group is practically exclusively regressed and the C 21 alcohol (10) is obtained in an isolated yield of more than 70%.
  • R in the compounds of the general formula I is preferably a hydrocarbon radical with in particular not more than 20 C atoms, advantageously not more than 10 C atoms.
  • Aliphatic radicals in particular those with 1-5, preferably 1-3 C atoms, are particularly preferred.
  • the most important residue is the methyl residue.
  • the partial reduction of the carboxyl or carboxylate group in C 21 according to the invention is also possible in the case of compounds which correspond to the general formula I and contain an additional olefinic double bond in the 9 (11) position.
  • A is a hydroxyl group in ⁇ - or ins special in the ß position means. If the starting compounds of the general formula I used according to the invention have a carbonyl group in A - ie A forms a carbonyl group with the C atom substituted by A in the 11-position - then this carbonyl group is also reduced to the corresponding hydroxyl group.
  • the 11 ⁇ -hydroxyl group is obtained, which is of particular importance anyway for pharmacological reasons.
  • the structure of the A-ring emerges unchanged from the process after completion of the 2-stage reduction and selective oxidation, this having particular technical significance for compounds with the ⁇ 1,4 -3-one structure in the A-ring.
  • the starting materials used according to the invention have a double bond in the side chain, moreover, in the preferred embodiment, have the A1,4-diene structure instead of the simpler A4 system and can also have an oxygen function in the 11-position or a further double bond in 9 (11) position. It was therefore not possible to predict with certainty that the reaction described by Eder would be transferable to the compounds used according to the invention.
  • CA 63, 13367 (1965) describes the improvement of the reduction of the compounds of the formula (5) to the diol of the formula (8) by using DIBAH instead of LiAIH 4 .
  • DIBAH instead of LiAIH 4 .
  • this is a reduction in a 4-en-3-keto system protected by enamine formation - cf. the formulas (6) and (8) presented above.
  • the reaction usually takes place in the temperature range from approximately -80 ° C. to + 30 ° C., the range from -30 ° C. to room temperature being preferred.
  • the temperature range from - 10 to + 5 ° C is particularly suitable.
  • the reaction is preferably carried out in the presence of inert solvents, for example aromatic hydrocarbons such as toluene or benzene, but aliphatic hydrocarbons such as hexane or ethers such as diethyl ether and the like are also suitable.
  • the reaction time is usually up to 10 hours and is preferably in the range from 2 to 5 hours.
  • the reaction is expediently carried out under protective gas, for example under N 2 .
  • the work is done in an anhydrous atmosphere.
  • DIBAH inert solvent
  • the amount of DIBAH used corresponds at least to the stoichiometrically required amount, preferably a slight excess, for example up to 20%, preferably up to about 10% molar excess is used.
  • a slight excess for example up to 20%, preferably up to about 10% molar excess is used.
  • each keto group needs one Equivalent share of DIBAH.
  • the reaction temperature is usually in the range of about 0 to 40 ° C, but can also go beyond. It is expedient to work below 80 ° C.
  • Ketone / alcohol / mixtures are used as oxidizing agents. Suitable hydride acceptors are, for example, acetone, cyclohexanone or fluorenone mixed with isopropanol or tert. Butanol as an alcohol component.
  • the reaction time here is usually 2 to 20 hours, preferably 4 to 12 hours. The reaction is also carried out under anhydrous conditions.
  • the ketone is usually used in a large excess, for example 5 to 50 times, preferably 10 to 20 times the amount stoichiometrically required in order to balance the reaction in the desired direction move.
  • Both novel and known compounds can be produced by the method according to the invention.
  • New in the context of the unsaturated alcohols obtained according to the invention according to general formula II are the compounds which have the A '-3-one configuration in the A ring of the steroid skeleton and are unsubstituted in the 11 position or also in the 9 (11) position have another double bond.
  • these two new C 21-01 compounds are a further subject of the invention.
  • the compounds of general formula II obtained according to the invention are valuable products in steroid chemistry and in particular valuable intermediates in the production of pharmacologically active steroid compounds, in particular the prednisone and / or prednisolone series.
  • the use of the compounds of the general formula II obtained according to the invention for this last-mentioned purpose also falls within the scope of the present invention and is therefore a further subject of the technical teaching claimed here.
  • the hydroxyl group in C 21 is generally first esterified, in particular acetylated.
  • Acetylation is achieved, for example, by reacting the C 21-ol compound with acetic anhydride / pyridine or Acetic anhydride / triethylamine / dimethylaminopyridine.
  • new, partly known compounds are again obtained.
  • New compounds - and thus a further subject of the present invention - are the acetate of pregna-1,4,17 (20) -trien-3-one-21-ol and the corresponding compound with an additional olefinic double bond in 9 (11) -Position.
  • Known acetates of this type are corresponding compounds with the ⁇ 4-3-one configuration and / or an oxygen function in the 11-position.
  • the aqueous phase extracted 2 x with a little methylene chloride, the organic phases are separated, washed to neutrality, then together over Na 2 S0 4 g concentrated e-dried and after removal of the drying agent to dryness.
  • the residue is chromatographed on silica gel with methylene chloride / ethyl acetate (75:25). 2.04 g (72%) of the product are obtained, which are uniform according to thin-layer chromatogram and 1 H-NMR spectrum.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
EP81103421A 1980-05-16 1981-05-06 Procédé de réduction partielle d'acides stéroide-21-carboxyliques et de leurs esters en stéroide-21-alcools Expired EP0040355B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0262880A AT373901B (de) 1980-05-16 1980-05-16 Verfahren zur partiellen reduktion von delta 4,17 (20)- sowie gegebenenfalls weitere doppelbindungen in 1- und/oder 9(11)-stellung aufweisenden c 21 -steroidcarbonsaeuren und ihren estern
AT2628/80 1980-05-16

Publications (3)

Publication Number Publication Date
EP0040355A2 true EP0040355A2 (fr) 1981-11-25
EP0040355A3 EP0040355A3 (en) 1982-01-20
EP0040355B1 EP0040355B1 (fr) 1984-07-25

Family

ID=3537652

Family Applications (1)

Application Number Title Priority Date Filing Date
EP81103421A Expired EP0040355B1 (fr) 1980-05-16 1981-05-06 Procédé de réduction partielle d'acides stéroide-21-carboxyliques et de leurs esters en stéroide-21-alcools

Country Status (5)

Country Link
US (1) US4370271A (fr)
EP (1) EP0040355B1 (fr)
JP (1) JPS579798A (fr)
AT (1) AT373901B (fr)
DE (1) DE3117562A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128508B1 (fr) * 1983-06-08 1991-04-10 Hitachi Metals, Ltd. Méthode et dispositif pour la fabrication des aimants anisotropes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE649669A (fr) * 1963-06-24
DE2558077A1 (de) * 1975-12-19 1977-06-30 Schering Ag Verfahren zur herstellung von 17(20)-dehydro-steroidderivaten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189430A (en) * 1978-07-31 1980-02-19 The Upjohn Company Epoxide process
NL8001346A (nl) * 1979-03-08 1980-09-10 Montedison Spa Werkwijze voor het katalytisch reduceren van carbonyl- verbindingen.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE649669A (fr) * 1963-06-24
DE1226576B (de) * 1963-06-24 1966-10-13 Upjohn Co Verfahren zur Herstellung von in 17(20)-Stellung ungesaettigten Pregnan-21-alkoholen
DE2558077A1 (de) * 1975-12-19 1977-06-30 Schering Ag Verfahren zur herstellung von 17(20)-dehydro-steroidderivaten

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemical Pharmaceutical Bulletin, Band 24, Nr. 4, April 1976, seiten 828-831 H. SAKAMOTO et al.: "Chemical Modifications of Androsta-1,4-Deine-3,17-Dione. III. The Synthesis of (20R)-17 alfa,20,21-Trihudroxypregna-1,4-Dien-3-One and its Derivatives" * seite 829, Verbindung IV; seite 830 * *
Chemische Berichte, Band 109, Nr. 8, August 1976, seiten 2954-2955 Weinheim, DE. U. EDER: "Notiz uber Testosteron aus 4-Androsten-3,17-Dion durch Diisobutylaluminiumhydrid-Reduktion und Selektive "in situ"- Oppenauer-Oxidation" * insgesamt * *

Also Published As

Publication number Publication date
AT373901B (de) 1984-03-12
EP0040355B1 (fr) 1984-07-25
EP0040355A3 (en) 1982-01-20
US4370271A (en) 1983-01-25
ATA262880A (de) 1983-07-15
DE3117562A1 (de) 1982-07-01
JPS579798A (en) 1982-01-19

Similar Documents

Publication Publication Date Title
DE2920290C2 (fr)
CH505802A (de) Verfahren zur Herstellung von Estern von 17a-Hydroxysteroiden der Pregnanreihe
WO1992014746A1 (fr) Composes de depart pour la fabrication de calcitriol et de ses derives, procede d'obtention de ces composes de depart et produits intermediaires pour ce procede
DE1643105A1 (de) Verfahren zur Herstellung von delta?-Ketosteroiden
EP0040355B1 (fr) Procédé de réduction partielle d'acides stéroide-21-carboxyliques et de leurs esters en stéroide-21-alcools
DE1468410A1 (de) Verfahren zur Herstellung von 16-Methylensteroiden
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
EP0023006B1 (fr) Procédé de préparation de stéroides insaturés
EP0005758B1 (fr) Procédé de synthèse de la chaîne latérale hydroxy acétylique de stéroides prégnaniques, 21-hydroxy-20-oxo-17alpha prégnanes et préparations pharmaceutiques les contenant
DE1568502C3 (de) 3-Cyanmethylen-androstene und -östrene und Verfahren zu ihrer Herstellung
EP0039893B1 (fr) Procédé de dégradation du groupe-20-carboxy de delta-4 BNC (bis nor cholane) contenant éventuellement d'autres liaisons ainsi que des stéroides à 21 carbones
DE4301461A1 (de) Verfahren zur Herstellung von Derivaten des Estra-1,3,5(10),14-tetraen-3,17alpha-diols
DE2046640B2 (de) Verfahren zur herstellung von delta hoch 4 -3-oxo-l alpha-methyl-steroiden
DE881945C (de) Verfahren zur Herstellung therapeutisch wertvoller Alkohole der Cyclopentanopolyhydrophenanthrenreihe
DE4319998A1 (de) Verfahren zur Herstellung von Derivaten des Estra-1,3,5(10),14-tetraen-3,17alpha-diols
DE2409971A1 (de) 5-cholestenderivate und verfahren zu ihrer herstellung
EP0041612B1 (fr) Procédé de préparation de 20-Carbonylsteroides par dégradation d'acides stéroide-22-carboxyliques
AT248039B (de) Verfahren zur Herstellung von 17α-Acyloxy-21-hydroxy-steroiden
DE2011559B2 (de) Verfahren zur herstellung von 9alpha-chlor-11beta-hydroxysteroiden
DE2531145A1 (de) Verfahren zur herstellung von 11beta-hydroxy-18-alkyl-steroiden der oestranreihe
DE2141127A1 (de) Neues verfahren zur herstellung wertvoller steroidderivate und zwischenprodukte fuer dieselben
DE1241825B (de) Ver fahren zur Herstellung von 6 Chlor 4 6diLirverbindungen der Pregnan-, Androstan oder Cholestanreihe
DE2230287A1 (de) Verfahren zur herstellung von 11betahydroxy-16alpha-methyl-steroiden
DD202439A5 (de) Verfahren zur herstellung von acyloxysteroiden
DE1166775B (de) Verfahren zur Herstellung von 19-nor-í¸-3-Ketosteroiden

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): BE CH FR LI NL

17P Request for examination filed

Effective date: 19811028

RBV Designated contracting states (corrected)

Designated state(s): AT BE CH FR GB IT LI LU NL SE

AK Designated contracting states

Designated state(s): BE CH FR LI NL

RBV Designated contracting states (corrected)

Designated state(s): BE CH FR LI NL

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): BE CH FR LI NL

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19870531

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19880531

Ref country code: CH

Effective date: 19880531

BERE Be: lapsed

Owner name: HENKEL K.G.A.A.

Effective date: 19880531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19881201

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19890131

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Effective date: 19890531